Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimax Holdings BhdXKLS:0222 70 FCF Margin % is 5.48% as of Mar. 2026, which is 56% below its 10-year median of 12.49. GuruFocus rates XKLS:0222 with a GF Score™ of 70/100 and a GF Value™ of RM0.77 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Optimax Holdings Bhd ranks better than 91% on this metric.
The historical rank and industry rank for Optimax Holdings Bhd's FCF Margin % or its related term are showing as below:
XKLS:0222'
s FCF Margin % Range Over the Past 10 Years
Min: -31.62 Med: 12.49 Max: 20.71
Current: 18.31
During the past 10 years, the highest FCF Margin % of Optimax Holdings Bhd was 20.71%. The lowest was -31.62%. And the median was 12.49%.
XKLS:0222's FCF Margin % is ranked better than 91% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 3.15
vs XKLS:0222: 18.31
The historical data trend for Optimax Holdings Bhd's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0222 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Optimax Holdings Bhd's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimax Holdings Bhd FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optimax Holdings Bhd's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Optimax Holdings Bhd's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optimax Holdings Bhd (XKLS:0222) has a FCF Margin % of 5.48% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Optimax Holdings Bhd and its competitors. This is 56% below median its historical median of 12.49. According to the industry distribution chart, Optimax Holdings Bhd ranks #60 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 9%.
Is Optimax Holdings Bhd's FCF Margin % too high?
Optimax Holdings Bhd's current FCF Margin % of 5.48% is 56% below median its 10-year median of 12.49. The Healthcare Providers & Services industry median FCF Margin % is 3.15. Optimax Holdings Bhd's value of 5.48% is 74% above this industry median. Based on the distribution chart, Optimax Holdings Bhd ranks #60 out of 667 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Optimax Holdings Bhd has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Optimax Holdings Bhd's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Optimax Holdings Bhd ranks #60 out of 667 companies for FCF Margin %. This places Optimax Holdings Bhd in the top 9% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.15. Optimax Holdings Bhd's value of 5.48% is 74% above this benchmark. While the company's 10-year median is 12.49 vs. the industry median of 3.15, Optimax Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.15, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimax Holdings Bhd's current FCF Margin % of 5.48% is 74% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Optimax Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimax Holdings Bhd's current FCF Margin % is 5.48%, which is 56% below median its own 10-year median of 12.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimax Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Optimax Holdings Bhd (XKLS:0222) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.77, compared to a current price of RM0.53 — trading 31.8% below its estimated fair value. The current FCF Margin % is 5.48%, which is 56% below median its 10-year median of 12.49 and 74% above the Healthcare Providers & Services industry median of 3.15. Optimax Holdings Bhd's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Optimax Holdings Bhd (XKLS:0222), the current FCF Margin % is 5.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimax Holdings Bhd (XKLS:0222) Overvalued in 2026?
Based on GuruFocus' analysis, Optimax Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.53 is trading 31.8% below its estimated GF Value™ of RM0.77.
GuruFocus considers Optimax Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0222:
FCF Margin %: 5.48% (56% below median its 10-year median of 12.49)
GF Value™: RM0.77 vs. price of RM0.53 (31.8% below fair value)
Industry Position: 74% above the Healthcare Providers & Services median (#60 of 667)
No single metric tells the full story. See the XKLS:0222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimax Holdings Bhd is a provider of eye specialist services. The company offers a range of services with in-house medical ophthalmology at specialist centres such as specialist clinics, ambulatory care centres, satellite clinics, and specialist hospitals. The company's ambulatory care centres and specialist hospital are equipped with eye operation theatres, and procedure rooms, general and day care wards, and relevant equipment for surgical procedures. It derives revenue from refractive surgery, treatment of eye diseases and disorders, consultation and dispensary services, oculoplastic surgery, plastic Surgery and aesthetic Services and related services. The company operates in geographical segments such as: North Malaysia, Central Malaysia, South Malaysia, East Malaysia and Cambodia.
70GF Score
Get the complete analysis for XKLS:0222
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0222 has been successfully added to your 
